Head to head
Arxis vs SpaceX
Side-by-side on the measures that matter, with a plain-English read. Full detail: ARXS · SPCX
ARXS
Arxis
48.46-5.94%
1-year price shape — not enough history yet
Quant Rating C · 0/100
vs
SPCX
SpaceX
127.79-7.69%
1-year price shape — not enough history yet
Quant Rating C · 0/100
1-year performance, rebased to 100
Arxis edges it on the scoreable measures. Arxis earns the most per share.
| ARXS | SPCX | |
|---|---|---|
| Snapshot | ||
| Sector | Aerospace & Defense | Aerospace & Defense |
| Last price | 48.46 | 127.79 |
| Change today | -5.94% | -7.69% |
| 1-year return | -- | -- |
| Market cap | $20.87B | $1.74T |
| 52-week range | 33.15 – 61.50 | 104.83 – 225.64 |
| Valuation | ||
| P/E (TTM) | 145.96 | -505.10 |
| P/E percentile, own 5-yr range | 9th | 12th |
| P/B | 3.90 | 9.82 |
| Dividend yield | 0.00% | 0.00% |
| Profitability & growth | ||
| EPS (TTM) | -0.12 | -0.38 |
| Net profit (TTM) | $-51.69M | $-5.13B |
| Revenue (TTM) | $1.93B | $32.04B |
| Provider revenue period date | 2026-09-29 | 2026-09-29 |
| Revenue growth (YoY) | +36.0% | +161.4% |
| Gross margin | 51.7% | 56.7% |
| Operating margin | 7.7% | -2.0% |
| Net margin | 6.5% | -10.7% |
| Free cash flow (TTM) | $394.40M | $-40.16B |
| Provider cash-flow period date | 2026-09-29 | 2026-09-29 |
| Ownership & sentiment | ||
| Institutional ownership | 95.6% | 30.3% |
| Insider activity (12mo) | 21 buy / 2 sell | 5 buy / 5 sell |
| Short interest (% of float) | 1.5% | 1.0% |
| Analyst consensus | 100% buy (6) | 87% buy / 10% hold / 3% sell (30) |
| Analyst price target | $66 (+36%) | $258 (+102%) |
| StockVane view | ||
| StockVane Quant Rating | C (0) | C (0) |
| Company | ||
| Employees | 5,753 | 22,000 |
| Founded | -- | 2002 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.